Dr Andrew Brockway
Chief Executive Officer
→ Register Your Interest
English
Julia is an Early Career Researcher and General Practitioner with sub-specialty training in tropical medicine, public health and vaccinology.
She is a Clinician–Scientist at The Peter Doherty Institute for Infection and Immunity. With collaborators, Julia led development of the first controlled human infection model of aerosol BCG to aid in tuberculosis vaccine development and co-led the world’s first SARS-CoV-2 human re-infection challenge model. She has also been involved in phase 1/2 studies towards the development of the Oxford-AstraZeneca vaccine and the R21/Matrix-M™ malaria vaccine.
A skills-based board combines comprehensive experience in academic research, financial strategy, commercial development and biotechnology & pharmaceutical industries. Along with the specialised leadership team, this expertise drives Doherty Clinical Trials Ltd unique capabilities.
Chief Executive Officer
Chief Medical Officer
Senior Program Manager
.png)
Clinical Operations and Nursing Director
Quality and Compliance Director
Human Infection Challenge Trial Consultant
Director
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}